ECZACIBASI TO INVEST OVER EUR 250M ON ITS 80TH ANNIVERSARY

The pharmaceutical company Eczacibasi Group plans to invest over EUR 250m in its operations, create more than 1,500 new jobs, and reach an annual turnover of over EUR 150m in 2022 when it celebrates its 80th anniversary, according to Atalay Gumrah, CEO of Eczacibasi. “We’ll primarily develop our R&D activities in nuclear medicine and invest in growth abroad. Collaboration with international organizations which have experience in this field is on our radar,” said Gumrah. Eczacibasi will also put into use its new manufacturing plant for VitrA Karo, the ceramic tiles firm incorporated by Eczacibasi. It will also invest in its fifth production plant in Bozuyuk to manufacture ceramic medical devices and will set up its fifth paper products facility in Manisa.

“Our factory in Morocco will allow us to penetrate the African paper products market. We’ll also invest in Russia. We are also continuing investments in natural resources to facilitate reserve and capacity increase,” said Gumrah. Digital transformation in health is also on the group’s radar. “We are evaluating possible partners and alternative service areas in digital health for the near future,” Gumrah added.